We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New PET/CT Imaging Protocol Improves Detection of Cardiac Sarcoidosis

By HospiMedica International staff writers
Posted on 02 Aug 2017
Researchers have shown that a new PET/CT imaging technique can enable much more accurate diagnoses of a rare condition called cardiac sarcoidosis than current tests.

The inflammatory disease is difficult to diagnose and in 40% of cases can affect multiple organs such as the heart, lungs, and lymph nodes. More...
Separate Positron Emission Tomography (PET) and Computed Tomography (CT) scans, and combined PET/CT imaging is often used for cardiac sarcoidosis diagnoses but can also result in many false negatives.

The study was carried out by researchers from the University of Illinois at Chicago (UIC; Chicago, IL, USA) and published online in the July 5, 2017, issue of the Journal of Nuclear Cardiology. The study group of 188 patients underwent full-body PET/CT scans at the University of Illinois Hospital (UI Health). The new protocol was used to study the relationship between cardiac sarcoidosis and sarcoidosis in other organs and included a high-fat, low-sugar diet for 72-hours before image acquisition.

The results showed that the new scanning protocol provides much clearer images and improves the detection of cardiac sarcoidosis. The results showed that eight of the 20 scans that were positive for cardiac sarcoidosis also showed sarcoidosis in other parts of the patients’ bodies.

One of the authors of the paper, Dr. Nadera Sweiss, professor of rheumatology at UIC College of Medicine, said, "We wanted to know if patients being evaluated for cardiac sarcoidosis would benefit from more thorough imaging of the body beyond the usual torso scan, using this new technique. This study indicates that more extensive, full-body scans of patients with known cardiac sarcoidosis can uncover secondary sites of the disease in a significant number of patients. Knowing there is disease in organs other than the heart changes the way we approach treatment – it allows us to more accurately stage the disease and treat it accordingly."

Related Links:
University of Illinois at Chicago
University of Illinois Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.